Coloma Jason V sold MAZE
August 3, 2026 · Form 4 insider transaction
Coloma Jason V sold 30,304 shares of Maze Therapeutics, Inc. at $26.71 per share, a transaction worth $809.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
30,304
Price
$26.71
Total value
$809.5K
InsiderColoma Jason V
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after256,867
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.005 to $26.985 per share, inclusive.; These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.